Cheng, Seng H.
Sanofi,
United States
2025 Rank: 162,374
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 727 out of 66,225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162,374 | 182,951 |
| Total Cites | 839 | 891 |
| H-index | 14 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 45 | 45 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 195 | 206 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 645 | 676 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.32 |
| Self-Citation Percentage |
5.84%
|
|
Cheng, Seng H.
Pfizer Inc.,
United States
2024 Rank: 186,998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 896 out of 62,673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186,998 | 206,086 |
| Total Cites | 757 | 796 |
| H-index | 14 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 30 | 30 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 202 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 588 | 615 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.29 |
| Self-Citation Percentage |
4.90%
|
|
Cheng, Seng H.
Pfizer Inc.,
United States
2023 Rank: 179,052
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 873 out of 59,267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 179,052 | 198,725 |
| Total Cites | 824 | 897 |
| H-index | 14 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 51 | 51 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 200 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 639 | 673 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
8.14%
|
|
Cheng, Seng H.
Sanofi S.A.,
United States
2022 Rank: 93,265
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 369 out of 56,174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93,265 | 107,026 |
| Total Cites | 952 | 1,020 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 52 | 52 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 220 | 228 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 734 | 765 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
6.67%
|
|
Cheng, Seng H.
Sanofi S.A.,
United States
2021 Rank: 113,852
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 473 out of 52,513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113,852 | 128,435 |
| Total Cites | 1,363 | 1,451 |
| H-index | 18 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 81 | 81 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 293 | 303 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,039 | 1,085 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.34 |
| Self-Citation Percentage |
6.06%
|
|
Cheng, Seng H.
Sanofi S.A.,
United States
2020 Rank: 118,785
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Respiratory System
Rank in SubField 1: 519 out of 50,343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118,785 | 127,864 |
| Total Cites | 1,086 | 1,184 |
| H-index | 16 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 62 | 62 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 224 | 238 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 814 | 856 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
8.28%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.